NCT01399190View on ClinicalTrials.gov

An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer

CompletedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

Bevacizumab

Bevacizumab administered according to prescribing information and normal clinical practice.

BIOLOGICAL

Capecitabine

Capecitabine administered according to prescribing information and normal clinical practice.

DRUG

Oxaliplatin

Capecitabine administered according to prescribing information and normal clinical practice.

Trial Locations (9)

975 17

Banská Bystrica

812 50

Bratislava

833 10

Bratislava

04001

Košice

036 59

Martin

950 01

Nitra

058 01

Poprad

081 81

Prešov

03426

Ružomberok

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01399190 - An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer | Biotech Hunter | Biotech Hunter